Lachey Jennifer

Chief Scientific Officer at KROS

Sold, on record
$6.3M
Dollars the filings state
Form 4 sales
17
Latest Jul 15, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • KROSKeros Therapeutics, Inc.Chief Scientific Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale KROSPlan not stated
    Jan 11, 2022 2022

    Sold 2,650 shares at $53.75 ($142k)

    Lachey Jennifer, Chief Scientific Officer

    Sold 3% of holdings ($4.7M position)85,700 shares left0.5x usual sizeFiling

  2. 2 Form 4 sale KROSPlan not stated
    Feb 11, 2022 +31 days

    Sold 2,650 shares at $52.06 ($138k)

    Lachey Jennifer, Chief Scientific Officer

    Sold 3% of holdings ($4.6M position)85,700 shares left0.7x usual sizeFiling

  3. 3 Form 4 sale KROSPlan not stated
    Mar 11, 2022 +28 days

    Sold 2,650 shares at $53.38 ($141k)

    Lachey Jennifer, Chief Scientific Officer

    Sold 3% of holdings ($4.7M position)85,700 shares left1x usual sizeFiling

  4. 4 Form 4 sale KROSUnusual
    Apr 4, 2022 +24 days

    Sold 7,950 shares at $60.00 ($477k)

    Lachey Jennifer, Chief Scientific Officer

    Sold 8.5% of holdings ($5.6M position)85,700 shares left3x usual sizeFiling

  5. 5 Form 4 sale KROSPlan not stated
    Apr 11, 2022 +7 days

    Sold 5,300 shares at $62.77 ($333k)

    Lachey Jennifer, Chief Scientific Officer

    Sold 5.8% of holdings ($5.7M position)85,700 shares left2x usual sizeFiling

  6. 6 Form 4 sale KROSPlan not stated
    May 11, 2022 +30 days

    Sold 5,300 shares at $41.90 ($222k)

    Lachey Jennifer, Chief Scientific Officer

    Sold 5.8% of holdings ($3.8M position)85,700 shares left1.3x usual sizeFiling

  7. 7 Form 4 sale KROSPlan not stated
    Jul 13, 2022 +63 days

    Sold 1,916 shares at $30.00 ($57k)

    Lachey Jennifer, Chief Scientific Officer

    Sold 2% of holdings ($2.9M position)95,100 shares left0.4x usual sizeFiling

  8. 8 Form 4 sale KROSUnusual
    Jul 15, 2022 +2 days

    Sold 46,034 shares at $30.00 ($1.4M)

    Lachey Jennifer, Chief Scientific Officer

    Sold 32.6% of holdings ($4.2M position)95,100 shares left11.6x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (17)

Form 144 notices and Form 4 sales by Lachey Jennifer
Source
Jul 15, 2022Jul 19, 2022KROSChief Scientific OfficerForm 4 sale46,034$1.4M32.6%UnusualSEC
Jul 13, 2022Jul 15, 2022KROSChief Scientific OfficerForm 4 sale1,916$57k2.0%Plan not statedSEC
May 11, 2022May 13, 2022KROSChief Scientific OfficerForm 4 sale5,300$222k5.8%Plan not statedSEC
Apr 11, 2022Apr 13, 2022KROSChief Scientific OfficerForm 4 sale5,300$333k5.8%Plan not statedSEC
Apr 4, 2022Apr 6, 2022KROSChief Scientific OfficerForm 4 sale7,950$477k8.5%UnusualSEC
Mar 11, 2022Mar 15, 2022KROSChief Scientific OfficerForm 4 sale2,650$141k3.0%Plan not statedSEC
Feb 11, 2022Feb 15, 2022KROSChief Scientific OfficerForm 4 sale2,650$138k3.0%Plan not statedSEC
Jan 11, 2022Jan 13, 2022KROSChief Scientific OfficerForm 4 sale2,650$142k3.0%Plan not statedSEC
Jan 5, 2022Jan 7, 2022KROSChief Scientific OfficerForm 4 sale2,650$159k3.0%Plan not statedSEC
Dec 15, 2021Dec 15, 2021KROSChief Scientific OfficerForm 4 sale2,650$134k3.0%Plan not statedSEC
Nov 11, 2021Nov 12, 2021KROSChief Scientific OfficerForm 4 sale21,200$1.3M19.8%UnusualSEC
Nov 4, 2021Nov 5, 2021KROSChief Scientific OfficerForm 4 sale10,600$530k11.0%Plan not statedSEC
Jun 11, 2021Jun 15, 2021KROSChief Scientific OfficerForm 4 sale2,650$135k3.3%Plan not statedSEC
May 11, 2021May 13, 2021KROSChief Scientific OfficerForm 4 sale2,650$133k3.6%Plan not statedSEC
Apr 12, 2021Apr 14, 2021KROSChief Scientific OfficerForm 4 sale5,300$318k6.9%Plan not statedSEC
Mar 11, 2021Mar 15, 2021KROSChief Scientific OfficerForm 4 sale5,300$342k8.0%Plan not statedSEC
Feb 11, 2021Feb 16, 2021KROSChief Scientific OfficerForm 4 sale5,300$344k15.9%Plan not statedSEC